Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.4M Buy
205,802
+24,348
+13% +$8.68M 0.27% 77
2025
Q4
$59.4M Buy
181,454
+29,548
+19% +$9.37M 0.23% 101
2025
Q3
$42.9M Sell
151,906
-31,510
-17% -$9.14M 0.2% 139
2025
Q2
$51.2M Sell
183,416
-176,223
-49% -$49.9M 0.27% 91
2025
Q1
$112M Buy
359,639
+551
+0.2% +$163K 0.73% 13
2024
Q4
$93.6M Buy
359,088
+51,138
+17% +$15.2M 0.63% 19
2024
Q3
$99.2M Buy
307,950
+15,817
+5% +$5.17M 0.84% 20
2024
Q2
$91.3M Buy
292,133
+139,980
+92% +$41.1M 0.87% 19
2024
Q1
$43.3M Buy
152,153
+6,153
+4% +$1.8M 0.4% 69
2023
Q4
$42.1M Buy
146,000
+66,000
+83% +$18M 0.46% 65
2023
Q3
$21.5M Sell
80,000
-247,937
-76% -$61.9M 0.25% 121
2023
Q2
$72.8M Buy
327,937
+250,050
+321% +$58M 0.86% 22
2023
Q1
$18.8M Buy
77,887
+2,137
+3% +$525K 0.26% 111
2022
Q4
$19.9M Buy
+75,750
New +$20.3M 0.27% 111
2022
Q2
Sell
-165,187
Closed -$39.9M 799
2022
Q1
$39.9M Buy
165,187
+75,083
+83% +$17.3M 0.65% 33
2021
Q4
$20.3M Sell
90,104
-4,357
-5% -$920K 0.29% 93
2021
Q3
$20.1M Buy
94,461
+53
+0.1% +$12.2K 0.33% 83
2021
Q2
$23M Buy
94,408
+10,047
+12% +$2.47M 0.43% 59
2021
Q1
$21M Sell
84,361
-416,159
-83% -$99.3M 0.47% 67
2020
Q4
$115M Buy
+500,520
New +$115M 3.05% 1
2020
Q1
Sell
-124,090
Closed -$29.9M 137
2019
Q4
$29.9M Buy
+124,090
New +$27.4M 1.22% 28

Other funds holding AMGN

Woodline Partners's AMGN Position: Q1 2026 in Review

Woodline Partners increased its Amgen (AMGN) stake by 13% in Q1 2026, buying an estimated $8.68M and bringing the position to 205,802 shares worth $72.4M. The position accounts for 0.27% of the portfolio, ranked #77.

Woodline Partners first reported a position in AMGN in Q4 2019 and has held it in 21 quarters since. The position peaked at $115M in Q4 2020. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Woodline Partners held 205,802 shares of Amgen worth $72.4M as of Q1 2026.
  • Woodline Partners bought 24,348 Amgen shares in Q1 2026, an estimated $8.68M.
  • Amgen made up 0.27% of Woodline Partners's portfolio in Q1 2026, its #77 holding.
  • Woodline Partners first reported a position in Amgen in Q4 2019 and has held it in 21 quarters since.
  • Woodline Partners's Amgen position peaked at $115M in Q4 2020.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.